Peripheral natural killer cells exhibit qualitative and quantitative changes in patients with psoriasis and atopic dermatitis

British Journal of Dermatology

Volumn 166, Issue 4, 2012, Pages 789-796

  Luci, C ^a   Gaudy Marqueste, C ^b   Rouzaire, P ^c,d,e   Audonnet, S ^d,f,g,h   Cognet, C ^d,f,g,h   Hennino, A ^c,d,e   Nicolas, J F ^c,d,e   Grob, J J ^b   Tomasello, E ^d,g,h  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^c UNIVERSITÉ DE LYON   (France)

^d INSERM   (France)

^e CENTRE HOSPITALIER LYON SUD   (France)

^f HÔPITAL DE LA CONCEPTION   (France)

^g CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^h CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; NATURAL KILLER CELL RECEPTOR;

ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CELL FUNCTION; CELL ISOLATION; CELL STIMULATION; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; INNATE IMMUNITY; MALE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; DERMATITIS, ATOPIC; FEMALE; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; PHENOTYPE; PSORIASIS;

EID: 84859161653     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10814.x     Document Type: Article

References (30)

1. Wilsmann-Theis D, Hagemann T, Jordan J, et al. Facing psoriasis and atopic dermatitis: are there more similarities or more differences? Eur J Dermatol 2008; 18: 172-80.
2. Lebwohl M,. Psoriasis. Lancet 2003; 361: 1197-204.
3. Bieber T,. Atopic dermatitis. N Engl J Med 2008; 358: 1483-94.
4. von Bubnoff D, Andres E, Hentges F, et al. Natural killer cells in atopic and autoimmune diseases of the skin. J Allergy Clin Immunol 2010; 125: 60-8.
5. Freud AG, Caligiuri MA,. Human natural killer cell development. Immunol Rev 2006; 214: 56-72.
6. Vivier E, Tomasello E, Baratin M, et al. Functions of natural killer cells. Nat Immunol 2008; 9: 503-10.
7. Guia S, Cognet C, de Beaucoudrey L, et al. A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo. Blood 2008; 111: 5008-16.
8. Walzer T, Jaeger S, Chaix J, et al. Natural killer cells: from CD3(-)NKp46(+) to post-genomics meta-analyses. Curr Opin Immunol 2007; 19: 365-72.
9. Walzer T, Blery M, Chaix J, et al. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc Natl Acad Sci USA 2007; 104: 3384-9.
10. Luci C, Reynders A, Ivanov II, et al. Influence of the transcription factor RORgammat on the development of NKp46(+) cell populations in gut and skin. Nat Immunol 2009; 10: 75-82.
11. Sanos SL, Bui VL, Mortha A, et al. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46(+) cells. Nat Immunol 2009; 10: 83-91.
12. Cella M, Fuchs A, Vermi W, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009; 457: 722-5.
13. Satoh-Takayama N, Vosshenrich CA, Lesjean-Pottier S, et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 2008; 29: 958-70.
14. Cupedo T, Crellin NK, Papazian N, et al. Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC(+) CD127(+) natural killer-like cells. Nat Immunol 2009; 10: 66-74.
15. Vivier E, Raulet DH, Moretta A, et al. Innate or adaptive immunity? The example of natural killer cells. Science 2011; 331: 44-9.
16. Ebert LM, Meuter S, Moser B,. Homing and function of human skin (gamma)(delta) T cells and NK cells: relevance for tumor surveillance. J Immunol 2006; 176: 4331-6.
17. Ottaviani C, Nasorri F, Bedini C, et al. CD56(bright)CD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol 2006; 36: 118-28.
18. Buentke E, Heffler LC, Wilson JL, et al. Natural killer and dendritic cell contact in lesional atopic dermatitis skin -Malassezia-influenced cell interaction. J Invest Dermatol 2002; 119: 850-7.
19. Cameron AL, Kirby B, Griffiths CE,. Circulating natural killer cells in psoriasis. Br J Dermatol 2003; 149: 160-4.
20. Katsuta M, Takigawa Y, Kimishima M, et al. NK cells and gamma delta+ T cells are phenotypically and functionally defective due to preferential apoptosis in patients with atopic dermatitis. J Immunol 2006; 176: 7736-44.
21. Gilhar A, Ullmann Y, Kerner H, et al. Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: induction of psoriasis by cells with natural killer receptors. J Invest Dermatol 2002; 119: 384-91.
22. Uhrberg M,. The CD107 mobilization assay: viable isolation and immunotherapeutic potential of tumor-cytolytic NK cells. Leukemia 2005; 19: 707-9.
23. Gregoire C, Chasson L, Luci C, et al. The trafficking of natural killer cells. Immunol Rev 2007; 220: 169-82.
24. Son SW, Kim EO, Ryu ES, et al. Upregulation of Fas and downregulation of CD94/NKG2A inhibitory receptors on circulating natural killer cells in patients with new-onset psoriasis. Br J Dermatol 2009; 161: 281-8.
25. Martin-Fontecha A, Thomsen LL, Brett S, et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004; 5: 1260-5.
26. Schlaak JF, Buslau M, Jochum W, et al. T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 1994; 102: 145-9.
27. Walzer T, Dalod M, Robbins SH, et al. Natural-killer cells and dendritic cells: 'l'union fait la force'. Blood 2005; 106: 2252-8.
28. Lee SH, Kim KS, Fodil-Cornu N, et al. Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection. J Exp Med 2009; 206: 2235-51.
29. Perona-Wright G, Mohrs K, Szaba FM, et al. Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells. Cell Host Microbe 2009; 6: 503-12.
30. Takahashi K, Aranami T, Endoh M, et al. The regulatory role of natural killer cells in multiple sclerosis. Brain 2004; 127: 1917-27.